IL104055A - Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases - Google Patents

Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases

Info

Publication number
IL104055A
IL104055A IL104055A IL10405592A IL104055A IL 104055 A IL104055 A IL 104055A IL 104055 A IL104055 A IL 104055A IL 10405592 A IL10405592 A IL 10405592A IL 104055 A IL104055 A IL 104055A
Authority
IL
Israel
Prior art keywords
ethanol
dimethyl
hydroxy
optically active
inhalants
Prior art date
Application number
IL104055A
Other languages
English (en)
Other versions
IL104055A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL104055A0 publication Critical patent/IL104055A0/xx
Publication of IL104055A publication Critical patent/IL104055A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL104055A 1991-12-14 1992-12-10 Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases IL104055A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4141350 1991-12-14

Publications (2)

Publication Number Publication Date
IL104055A0 IL104055A0 (en) 1993-05-13
IL104055A true IL104055A (en) 1998-04-05

Family

ID=6447111

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104055A IL104055A (en) 1991-12-14 1992-12-10 Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases

Country Status (19)

Country Link
US (1) US5310753A (fr)
EP (1) EP0547523B1 (fr)
JP (1) JP2625071B2 (fr)
CN (1) CN1073172A (fr)
AT (1) ATE122674T1 (fr)
AU (1) AU653874B2 (fr)
CA (1) CA2085166A1 (fr)
DE (1) DE59202242D1 (fr)
DK (1) DK0547523T3 (fr)
ES (1) ES2073850T3 (fr)
FI (1) FI925618A (fr)
HU (2) HUT67172A (fr)
IL (1) IL104055A (fr)
MX (1) MX9207216A (fr)
NO (1) NO300893B1 (fr)
NZ (1) NZ245447A (fr)
RU (1) RU2102391C1 (fr)
TW (1) TW244350B (fr)
ZA (1) ZA929616B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9510477D0 (en) * 1995-05-24 1995-07-19 Sandoz Ltd Organic compounds
FR2756284B1 (fr) * 1996-11-26 2000-04-28 Adir Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2505500C (fr) 2002-11-12 2009-08-18 Warner-Lambert Company Llc Methodes de stimulation de la croissance des cheveux au moyen de benzopyranes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2633605B1 (fr) * 1988-07-01 1991-07-12 Rhone Poulenc Chimie Procede de preparation d'oxyde de titane et d'articles a base d'oxyde de titane
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
GB8918298D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
AU653874B2 (en) 1994-10-13
RU2102391C1 (ru) 1998-01-20
JPH05255303A (ja) 1993-10-05
HUT67172A (en) 1995-02-28
JP2625071B2 (ja) 1997-06-25
TW244350B (fr) 1995-04-01
ATE122674T1 (de) 1995-06-15
NO300893B1 (no) 1997-08-11
ES2073850T3 (es) 1995-08-16
FI925618A0 (fi) 1992-12-10
DK0547523T3 (da) 1995-09-11
NZ245447A (en) 1994-09-27
FI925618A (fi) 1993-06-15
IL104055A0 (en) 1993-05-13
DE59202242D1 (de) 1995-06-22
CA2085166A1 (fr) 1993-06-15
EP0547523A1 (fr) 1993-06-23
NO924806D0 (no) 1992-12-11
CN1073172A (zh) 1993-06-16
MX9207216A (es) 1993-06-01
US5310753A (en) 1994-05-10
EP0547523B1 (fr) 1995-05-17
AU3017192A (en) 1993-06-17
HU9203928D0 (en) 1993-03-29
NO924806L (no) 1993-06-15
ZA929616B (en) 1993-06-18

Similar Documents

Publication Publication Date Title
KR20090016008A (ko) 11β-(4-아세틸페닐)-20,20,21,21,21-펜타플루오르-17-히드록시-19-노르-17α-프레그나-4,9-디엔-3-온의 결정질 형태
US20090197907A1 (en) Novel crystalline form of rupatadine free base
EP1716142A2 (fr) Derives d'oxazole, leur preparation et leur utilisation en therapeutique
TW458970B (en) Benzoylpyridazines having the activity in inhibiting phosphodiesterase IV
WO2005073200A1 (fr) Nouvelles formes cristallines d'un inhibiteur de la 11-beta-hydroxysteroide dehydrogenase de type 1
US5310753A (en) Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases
JPS62228057A (ja) 化学化合物
JPH05221980A (ja) アセチレン化合物
CA2260065C (fr) Procede de preparation de 4-cyano-1,2,3-triazoles 1-substitues
EP2057144A2 (fr) Nouveaux polymorphes de rimonabant
AU650569B2 (en) Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals
WO2011055233A2 (fr) Procédé amélioré pour préparer un polymorphe de célécoxib
EP0531078A1 (fr) (R)-3-Methoxy-4-(1-méthyl-5-(2-méthyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylméthyl)-N-(2-méthylsulphonyl)-benzamide en forme crystalline
DK155736B (da) Analogifremgangsmaade til fremstilling af 4-(1-imidazolylmethyl)kanelsyre-hydrochlorid-monohydrat
EP1925616A1 (fr) Procédé pour la préparation de formes crystallines de la cabergoline via des solvates stables de la cabergoline
CZ298518B6 (cs) Zpusob cištení Lorazepamu
WO2002060440A1 (fr) Nouvelles formes de 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide
JPH06199809A (ja) ２，５−ジブロモピリミジンの製造法
WO2004087682A1 (fr) Nouvelles formes cristallines de parecoxib sodique
WO2024209392A1 (fr) Procédé de préparation de pralsetinib sous forme amorphe
JPH0324047A (ja) フェニルマロン酸モノアニリド誘導体および３―フェニル―２―キノロン誘導体の製造方法
JPH01213271A (ja) 新規化学的方法
JPS5865296A (ja) 抗菌性化合物及びその組成物
JP2011500804A (ja) グルココルチコイド受容体リガンドの製造方法
IL195650A (en) Crystalline forms of 11beta-(4-acetylphenyl)-20,2021,21,21-pentafluoro-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void